Shetti Sandeep, Kumar C Dinesh, Sriwastava Neeraj Kumar, Sharma Indra Prakash
Department of Pharmacognosy, Manipal College of Pharmaceutical Sciences, Manipal - 576 104, India.
Pharmacogn Mag. 2011 Jan;7(25):69-73. doi: 10.4103/0973-1296.75905.
Currently, a majority of the adverse events related to the use of herbal products and herbal medicines that are reported are attributable either to poor product quality or to improper use. Inadequate regulatory measures, weak quality control systems, and largely uncontrolled distribution channels (including mail order and Internet sales) may have been contributing to the occurrence of such events. In order to expand the knowledge about genuine adverse reactions to herbal medicines, and to avoid wasting scarce resources for identifying and analyzing adverse events, events resulting from such situations will need to be reduced or eliminated. Member States of the World Health Organization (WHO) are therefore encouraged to strengthen national regulation, registration and quality assurance and control of herbal medicines. In addition, the national health authorities should give greater attention to consumer education and to qualified practice in the provision of herbal medicines.
目前，所报告的与使用草药产品和草药相关的大多数不良事件，要么归因于产品质量差，要么归因于使用不当。监管措施不足、质量控制系统薄弱以及基本上不受控制的分销渠道（包括邮购和互联网销售）可能一直在促使此类事件的发生。为了扩大对草药真正不良反应的认识，并避免浪费稀缺资源来识别和分析不良事件，需要减少或消除由这些情况导致的事件。因此，鼓励世界卫生组织（WHO）的成员国加强对草药的国家监管、注册以及质量保证和控制。此外，国家卫生当局应更加重视消费者教育以及提供草药时的规范操作。
